Cetya Therapeutics

Early-stage biotech developing drug candidates using a proprietary HDACi platform based on Largazole analogs

placeFort Collins, Colorado, United States calendar_todayFounded 2012 groups2 employees language cetya-therapeutics.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 133 times.

YearFilings
20221
20231
20241
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon